Loading...
Keywords
Last Name
Institution

Connection

Search Results to Jennifer L. Goldman

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Goldman, Jennifer

PropertyValue
keywords Pediatric Infectious Diseases
keywords Clinical Pharmacology
research overview Dr. Goldman’s current clinical and research interests include adverse drug reactions experienced by pediatric patients, particularly to antibiotics, and the overall impact of adverse drug reactions on antibiotic prescribing practices. She is interested in the mechanisms by which antibiotics cause severe drug reactions. Her long-term goal is to individualize therapeutic treatment in children that will allow for optimal care while minimizing undesired drug effects. Currently Dr. Goldman leads an interdisciplinary team to define mechanisms of adverse drug reactions associated with a commonly prescribed antibiotic (R01GM129783 PI: Goldman). She also serves as Medical Director of our hospital-wide Antimicrobial Stewardship Program (ASP). The ASP team includes physicians, pharmacists, nurses, and a data analyst. The overarching goal of the program is to optimize antibiotic therapy at Children’s Mercy. The program provides guidance on how to best use antibiotics daily throughout the hospital.

One or more keywords matched the following items that are connected to Goldman, Jennifer

Item TypeName
Concept Hospitals, Pediatric
Concept Pediatrics
Concept Intensive Care, Neonatal
Academic Article Development of biomarkers to optimize pediatric patient management: what makes children different?
Academic Article Trends in adverse reactions to trimethoprim-sulfamethoxazole.
Academic Article Cost and Potential Avoidability of Antibiotic-Associated Adverse Drug Reactions in Children.
Academic Article Pediatric Crohn disease presenting as appendicitis: differentiating features from typical appendicitis.
Academic Article No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates.
Academic Article Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation.
Academic Article Editorial Commentary: Pediatric Acute Kidney Injury: Is the Addition of Gentamicin Worth the Risk?
Academic Article New Horizons for Pediatric Antibiotic Stewardship.
Academic Article Tip of the Iceberg: Understanding the Unintended Consequences of Antibiotics.
Academic Article Clinical Impact of an Antimicrobial Stewardship Program on Pediatric Hospitalist Practice, a 5-Year Retrospective Analysis.
Academic Article Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees.
Academic Article Costs of Antimicrobial Stewardship Programs at US Children's Hospitals.
Academic Article Pharmacokinetic considerations in treating invasive pediatric fungal infections.
Academic Article A 9-Year-Old Boy With a Chest Mass and Eosinophilia.
Academic Article Variability in Antifungal and Antiviral Use in Hospitalized Children.
Academic Article A 16-Year-Old Girl With Eye Pain.
Academic Article Integrating staff nurses in antibiotic stewardship: Opportunities and barriers.
Academic Article Pediatric Pharmacovigilance: Enhancing Adverse Drug Reaction Reporting in a Tertiary Care Children's Hospital.
Academic Article Variability of surgical prophylaxis in penicillin-allergic children.
Academic Article To Discharge or Not to Discharge on Outpatient Parenteral Antimicrobial Therapy: That Is the Question.
Academic Article Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole.
Academic Article Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients.
Academic Article Big Data in the Assessment of Pediatric Medication Safety.
Academic Article Effectiveness and safety of mandatory antimicrobial indications and durations and a pharmacist-driven 48-hour time-out in a pediatric hospital.
Academic Article A Moving Target-Vancomycin Therapeutic Monitoring.

Search Criteria
  • Neonatal
  • Pediatric
  • Clinical Pharmacology